Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Deenan Pillay, Jan Deenan, Silvia Bertagnolio, Charles Boucher, Francoise Brun-Vezinet, Bonaventura Clotet, Carlo Giaquinto, Carlo F. Perno

Research output: Contribution to journalArticle

Abstract

Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

Original languageEnglish
Pages (from-to)831-836
Number of pages6
JournalAntiviral Therapy
Volume18
Issue number6
DOIs
Publication statusPublished - 2013

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this